We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Falsified, potentially harmful Ozempic▼ and Saxenda products have been found in the UK.
The DOVE tool shows the relationship between spending on diabetes care and clinical outcomes in GP and clinical commissioning group (CCG) areas.
Scientific risk assessment of nutrition and health claim applications and other nutrition-related matters after the transition period (1 January 2021).
Innovate UK-supported life science company Phynova finds further evidence that its plant-based food ingredient promotes healthy blood sugar.
False blood glucose readings when used to flush arterial lines leading to incorrect insulin administration and potentially fatal hypoglycaemia.
Cutaneous amyloidosis at the injection site has been reported in patients using insulin and this may affect glycaemic control. Remind patients to rotate injection sites within the same body region.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.